← Leaderboards
A Claudio Cuello
Mcgill University
$3,149,071
Attributed
$9,373,697
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,373,697 · 5
By mechanism
RF1$5,793,808 · 2
R01$3,579,889 · 3
Top collaborators
- Jorge A Busciglio5 shared
- Juan Fortea5 shared
- Thomas M Wisniewski5 shared
- David Fernando Aguillon4 shared
- Yakeel T. Quiroz4 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseMultidisciplinaryImpaired CognitionBiological MarkersAutopsyMetabolic DysfunctionS Disease PathologyNerve Growth FactorsUniversitiesMetabolismBrainCanadaPlasmaPatient PopulationNovel MarkerNerve DegenerationFutureCollaborationsProteinsTau ProteinsAmyloid Beta-ProteinPre-ClinicalMetabolic Pathway
Grant awards (12)
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$802,150
R01 · FY2025 · AG
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease$284,072
R01 · FY2025 · AG
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$259,200
R01 · FY2025 · AG
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease$195,927
R01 · FY2025 · AG
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease$147,065
R01 · FY2025 · AG
The role of immune deregulation and NGF dysmetabolism in the development of Alzheimer disease in individuals with Down syndrome$1,105,775
R01 · FY2024 · AG
Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease$1,969,396
RF1 · FY2022 · AG
The Role of Inflammation and NGF Dysfunction in the Evolution of AlzheimerDisease Pathology in Down syndrome$563,692
RF1 · FY2020 · AG
The Role of Inflammation and NGF Dysfunction in the Evolution of AlzheimerDisease Pathology in Down syndrome$3,260,720
RF1 · FY2018 · AG
Synaptic Alterations in the Cerebral Cortex during Aging$261,900
R01 · FY2005 · AG
Synaptic Alterations in the Cerebral Cortex during Aging$261,900
R01 · FY2004 · AG
Synaptic Alterations in the Cerebral Cortex during Aging$261,900
R01 · FY2003 · AG